🇺🇸

US SEC Filing Intelligence

· daily

US SEC Filings Daily Market Digest — September 28, 2026

Today's digest reveals a market bifurcated between high-stakes corporate actions and routine disclosures. The most critical developments cluster around several SPAC business combinations and delisting events, with GOWell Energy Technology's successful merger (backed by a $70M PIPE) and NOVAGOLD's transformative acquisition of Donlin Gold standing out as high-conviction catalysts. Conversely, the delisting of Platinum Analytics and the Nasdaq deficiency at Hub Cyber Security highlight acute distress in the micro-cap space. From a financial health perspective, period-over-period data shows a mixed picture: Armlogi's revenue declined 2.4% YoY while operating expenses surged 49.7%, contrasting with Kentucky First Federal Bancorp's impressive turnaround to a $1.9M net profit from a $1.7M loss. Insider activity is sparse but notable, with Hyperscale Data's Executive Chairman making small open-market purchases, while several On Holding AG directors had shares withheld for taxes, a routine non-discretionary event. The forward-looking catalyst calendar is dominated by the upcoming Wolfe Research Conference (Kinder Morgan) and a critical Nasdaq hearing for urban-gro on October 6th. Overall, the data suggests a 'risk-on' environment for select special situations and a cautious stance on companies with deteriorating fundamentals and regulatory overhangs.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — September 28, 2026

The two S&P 500 Healthcare filings for September 28, 2026, present a stark contrast in corporate activity. Medtronic's 425 filing details a major corporate separation of its MiniMed diabetes business via a large exchange offer, representing a high-materiality strategic catalyst with significant implications for capital structure and shareholder value. In contrast, Stryker's Form 4 reveals a routine, low-materiality insider stock disposal by its CFO, offering no actionable signal. The period-over-period, forward-looking, and capital allocation enriched data fields were not populated in these filings, limiting trend analysis. The dominant theme is the Medtronic-MiniMed separation, which creates a unique opportunity for investors to evaluate the sum-of-the-parts valuation and potential for value unlocking in the medical device sector.

2 high priority 2 total filings
· daily

US Earnings Financial Results SEC Filings — September 28, 2026

The 38 filings for the period ending September 28, 2026, reveal a market characterized by stark divergence: while a handful of companies like InterGroup Corp and Kentucky First Federal Bancorp show significant earnings turnarounds, a larger cohort is experiencing severe financial distress, widening losses, and balance sheet deterioration. The most prominent theme is the 'Digital Asset Contagion,' where companies like CleanCore Solutions, Lite Strategy, and Foxx Development have adopted digital asset treasury strategies, resulting in massive non-cash losses and volatility that obscure underlying operational performance. A second major theme is the 'SPAC & Blank Check Graveyard,' with filings from Invest Acquisition Corp, Ocean Capital Acquisition Corp, and Inflection Point Acquisition Corp VIII highlighting the challenges of this sector, including high cash burn, redemptions, and difficulty completing business combinations. Overall, the data points to a cautious environment where investors should prioritize companies with strong cash flows and tangible asset backing, while avoiding those with speculative strategies or deep insolvency.

38 high priority 38 total filings
· daily

US IPO Pipeline SEC S-1 Filings — September 28, 2026

The IPO pipeline on September 28, 2026, is dominated by SPAC activity, with three blank-check companies (Silicon Valley Acquisition Corp., Calm Seas Acquisition Corp., and Orange Street Acquisition Corp.) filing registration statements alongside two traditional operating companies (General Enterprise Ventures and HMH Holding). A key portfolio-level trend is the divergence in financial health: while the SPACs show no revenue and increasing losses (SVAQ's net loss widened 25% YoY to $1.23M), HMH Holding reveals a complete write-down of a $0 seller's receivable and rising unallocated costs ($8.9M to $10.8M YoY). General Enterprise Ventures carries significant debt with convertible notes at fixed prices ($2.40 and $2.16 per share), creating potential dilution. The most critical development is the SVAQ/EigenQ business combination, which brings a revenue-generating target into a SPAC structure. No insider trading activity was reported across any filing, limiting conviction signals. The pipeline suggests a market favoring SPAC structures for bringing companies public, but the underlying financials of the operating companies warrant caution due to deteriorating trends and contingent liabilities.

5 high priority 5 total filings
· daily

US SEC Trading Suspension Halt Orders — September 28, 2026

The two filings in this digest highlight a critical regulatory theme: small-cap companies are facing intense Nasdaq listing compliance pressure, with both Hain Celestial Group and Nexalin Technology receiving extensions but remaining under significant delisting risk. Hain Celestial's transfer to the Nasdaq Capital Market and extended 180-day compliance period through March 22, 2027, comes alongside the resignation of its Chief Accounting Officer, creating a dual overhang of governance and listing uncertainty. Nexalin Technology faces a more acute situation with a September 28, 2026 deadline to demonstrate a $1.00 closing bid price for 20 consecutive sessions, and a January 4, 2027 deadline to meet the $2.5M stockholders' equity requirement, with the company already ineligible for further extensions. Both companies exhibit negative sentiment and high materiality, with Nexalin at 9/10 and Hain at 8/10, indicating elevated risk of adverse outcomes. The concentration of these events on the same day (September 28, 2026) suggests a potential sector-wide pattern of micro-cap distress, possibly driven by broader market volatility or sector-specific headwinds. Investors should monitor these situations closely, as failure to meet conditions will likely result in immediate trading suspensions or delistings, creating significant downside risk for current shareholders.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — September 28, 2026

This digest of 27 filings reveals a significant wave of executive and director changes across US-listed companies, with a notable concentration of CFO departures and CEO transitions. The most critical development is MongoDB's immediate CEO departure to Meta, which, despite reaffirmed guidance, introduces leadership uncertainty at a key enterprise software player. A distinct pattern of CEO/CFO duality emerges, with CEOs at Matternet, Gain Therapeutics, and Jasper Therapeutics all assuming interim CFO roles, signaling potential resource constraints or strategic restructuring. The filings show a strong positive sentiment around new appointments, particularly at Adeia, Asana, and H.B. Fuller, where incoming leaders bring deep industry expertise and proven track records. While most filings lack direct financial period-over-period comparisons, the enriched data reveals important forward-looking signals, including performance-based incentive plans at Workhorse Group and Highwater Ethanol that tie executive compensation to specific operational milestones. The materiality of events varies widely, from routine governance updates at World Gold Trust to high-impact CEO changes at MongoDB and Adeia, underscoring the need for investors to differentiate between noise and actionable intelligence. Overall, the digest highlights a dynamic leadership landscape with implications for corporate strategy, operational continuity, and shareholder value creation across technology, healthcare, and industrial sectors.

27 high priority 27 total filings
· daily

US Corporate Board Director Changes SEC Filings — September 28, 2026

This digest covers 27 filings from September 28, 2026, focused on board room changes across US equities. The most critical development is the sudden CEO departure at MongoDB (MDB) to join Meta, a high-impact event mitigated by the immediate return of former CEO Dev Ittycheria and reaffirmed guidance, though it introduces leadership uncertainty. A notable positive is the CEO appointment at Adeia Inc. (ADEA), bringing deep semiconductor expertise from Arm, which could unlock value in its IP licensing business. A pattern of interim CFO appointments is emerging at several small/mid-cap firms (Gain Therapeutics, Jasper Therapeutics, Matternet), signaling potential financial control risks. The gold trust filings (GLDW, GLD) show routine governance updates with no material impact. Overall, the period shows a mix of proactive board strengthening (Asana, H.B. Fuller, Humacyte) and reactive departures, with the MongoDB event being the most actionable for investors.

27 high priority 27 total filings
· daily

USA Insider Trading Pulse — September 28, 2026

Today's filings reveal a bifurcated insider trading landscape: financials show insider buying at discounted valuations (DYNEX, Angel Oak), while tech and industrials see profit-taking and tax-related selling. Key signals include a large insider sale at Roblox ($5.33M), a 10% owner sale at an industrial ($1.81M), and insider accumulation in small-cap financials. No guidance changes or major capital allocation shifts were flagged, but the aggregate pattern suggests selective conviction rather than broad-based optimism.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — September 28, 2026

The US M&A and takeover landscape is dominated by SPAC activity, with 10 of 13 filings involving blank-check companies at various stages of business combinations. Notable de-SPAC completions include GOWell Energy Technology (IPEX) and the imminent Viking-NorthStar close, while high-profile new deals were announced for Astro Digital (Proem) and REDLattice (Bold Eagle), with valuations of $587M and $1.25B respectively. The filings reveal a bifurcated SPAC market: well-capitalized targets with strong revenue growth (Astro Digital 42% CAGR, REDLattice 29% YoY) are attracting committed capital, while others (Crown Reserve, Columbus, Wintergreen, Lakeshore) face repeated extensions and adjournments, signaling execution risk. Financial distress is evident in Cambium Networks' administration sale, and Greenpro's divestiture of six subsidiaries to an insider highlights strategic restructuring. Insider activity is limited but notable: Greenpro's sale to a director and Emmis's sponsor share transfer to a new director. Forward-looking data points to a catalyst-rich Q4 2026 and Q1 2027, with several deals expected to close by year-end. Overall, the market shows selective investor appetite, favoring targets with proven growth and profitability, while weaker SPACs struggle to complete transactions.

13 high priority 13 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 28, 2026

Overnight SEC filings reveal a market bifurcated between strategic growth moves and distress signals. Key themes include aggressive capital raises via SPAC mergers and ATMs (BOXABL, GOWell, Celularity), significant insider buying at Hyperscale Data, and major guidance raises at Gray Media on political ad strength. Conversely, several companies face existential risks: Platinum Analytics and urban-gro face delisting, GEE Group has a governance scandal, and multiple micro-caps (Golden Star, Greenway) show severe liquidity distress. Period-over-period data shows mixed earnings: Kentucky First Federal and Invest Acquisition turned profitable, while Armlogi and Vantage Corp saw losses widen. The EV/battery space shows strategic realignment (NIO-Geely, Amprius government contract), while gold miners (NOVAGOLD, SSR) signal consolidation. Overall, the digest highlights high-alpha opportunities in distressed assets and strategic transactions, alongside significant downside risks in governance and liquidity.

22 high priority 28 medium 50 total filings
· daily

DHS Homeland Security Contracts — September 27, 2026

The sole DHS contract in this digest, a $421.2M firm-fixed-price delivery order awarded to Loyal Source Government Services LLC by CBP for border medical screening in Donna, TX, represents a purely civilian (non-DOD) award with a neutral signal. The contract, won under full and open competition, is notable for its scale ($421M) but is tempered by the fact that its two-year performance period ended in September 2022, with only $212M of the obligation outlayed, leaving significant uncertainty about future revenue recognition. The highest-conviction signal is the competitive win itself, which underscores CBP's sustained investment in labor-intensive border medical services, though the fixed-price structure and completed performance period limit forward-looking visibility. The key risk is the lack of any indication of follow-on work or recompetition, making this a historical data point rather than a driver of future growth for Loyal Source or its investors.

1 total filings
· daily

New Federal Contractors — September 27, 2026

The two contracts analyzed represent a combined $1.03 billion in federal obligations, both awarded to civilian agencies (GSA and DHS) with zero defense-related spending, underscoring a continued focus on non-DOD IT and border security services. Parsons Government Services Inc. secured the largest award, a $612 million cost-plus-fixed-fee task order for computer systems design via GSA FEDSIM, while Loyal Source Government Services LLC won a $421 million firm-fixed-price delivery order for medical screening at the U.S.-Mexico border. Both contracts were competitively awarded with no set-asides, signaling strong market positions, but the negative outlayed amount on Parsons' award and the completed performance period on Loyal Source's contract temper forward-looking revenue visibility. The highest-conviction signal is the durability of border-related services spending, evidenced by Loyal Source's substantial award, though the fixed-price structure and past performance period introduce execution and revenue sustainability risks. Key watch items include potential recompetitions for both contracts and any budget adjustments reflected in outlayed amounts.

2 total filings
· daily

Significant Contract Modifications ($10M+) — September 27, 2026

The two September 2020 contract actions total $1.03B, all civilian (0% defense), with Parsons Government Services Inc. ($612M, GSA FEDSIM) and Loyal Source Government Services LLC ($421M, DHS/CBP) receiving large obligations for IT services and border medical screening, respectively. Both are neutral signals (materiality 6/10) as they are administrative modifications to existing contracts with past performance periods, not new growth awards. The dominant theme is civilian agency spending via competitive full-and-open awards, but a key risk is that both contracts lack near-term future revenue visibility: Parsons' task order ends March 2025 with negative net outlay, and Loyal Source's contract expired September 2022 with over half already outlayed. The highest-conviction signal is the absence of defense exposure in this digest, suggesting institutional investors should look elsewhere for DOD momentum. Key watch items are the recompetition of Parsons' task order and any new DHS/CBP border health solicitations.

2 total filings
· daily

Contract Deobligations Alert — September 27, 2026

This digest covers two contracts totaling $1.03 billion—both civilian awards with no defense exposure—highlighting a bifurcation in federal services spending: IT systems design via GSA and border medical screening via DHS. Parsons Corporation’s $612M cost-plus-fixed-fee delivery order is the highest-conviction signal due to materiality, though it is an administrative continuation with a finite March 2025 end date, limiting forward revenue visibility. Loyal Source’s $421M firm-fixed-price contract with CBP ended in September 2022, offering zero current revenue visibility. Key risk: the Parsons modification shows negative outlayed amounts, indicating budget reallocation rather than organic growth, while the Loyal Source contract’s completion removes near-term upside from this specific award.

2 total filings
· daily

Contract Option Exercises — September 27, 2026

The two contract option exercises total $1.03 billion in obligations, both awarded to civilian agencies (GSA and DHS) with zero defense-related content, signaling continued strength in non-defense federal IT and border security services. Parsons Corporation secured a $612M cost-plus-fixed-fee GSA FEDSIM delivery order for IT services in Washington, DC, though the negative outlayed amount and administrative continuation language suggest budget reallocation rather than organic growth. Loyal Source Government Services won a $421M firm-fixed-price DHS/CBP medical screening contract in Donna, TX, with $212M already outlayed and the performance period ended in 2022, limiting forward revenue visibility. The highest-conviction signal is the competitive, full-and-open nature of both awards, indicating these companies won on merit, but the neutral signal strength (5/10) and lack of defense exposure temper the investment thesis. Key watch items include the March 2025 end of Parsons' task order and potential recompetition, and any new DHS/CBP medical screening solicitations that could replace Loyal Source's expired contract.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — September 27, 2026

The sole contract in this digest is a $612.1 million cost-plus-fixed-fee delivery order awarded to Parsons Government Services Inc. via the General Services Administration (GSA) FEDSIM, for computer systems design services in Washington, DC. This is a civilian agency contract (0/1 defense-related), reflecting the GSA's role as a central procurement vehicle for IT services. The award, made under full and open competition, signals Parsons' competitive strength in the federal IT services market, though the negative outlayed amount and administrative continuation language suggest this is a modification or extension rather than a new award, tempering the bullish signal. The contract's performance period ends in March 2025, with no option periods, creating a near-term recompetition risk. The dominant theme is the stability of civilian IT services spending, but the lack of defense exposure and the administrative nature of the modification limit the investment conviction.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — September 27, 2026

The September 27, 2026 mega-contract stream, totaling $1.03 billion across two civilian awards, reflects a continued federal shift toward services-based spending rather than defense hardware, with zero defense-related obligations. Parsons Corporation's $612M GSA FEDSIM cost-plus-fixed-fee delivery order for IT systems design in Washington, DC, and Loyal Source Government Services' $421M DHS/CBP firm-fixed-price medical screening award in Donna, TX, both signal robust demand for professional and labor-intensive services. The highest-conviction signal is the competitive, full-and-open nature of both awards, indicating strong execution capabilities, though the Parsons modification's negative outlayed amount and Loyal Source's completed 2022 performance period temper forward-looking revenue visibility. Key watch items include potential recompetes for both contracts and the impact of continuing resolution uncertainty on civilian agency budgets.

2 total filings
· daily

High-Value Federal Grants ($5M+) — September 27, 2026

This digest covers two civilian-agency contracts totaling $1,033,265,582, with zero defense-related obligations. The dominant theme is federal service outsourcing to support border security and IT operations, led by a $612M GSA FEDSIM award to Parsons Government Services Inc. for computer systems design and a $421M DHS/CBP award to Loyal Source Government Services LLC for medical screening. The highest-conviction signal is the Loyal Source award, which demonstrates strong competitive positioning in border-related medical services, but its completed performance period limits forward-looking revenue visibility. A key risk is the extension/modification nature of the Parsons award, which implies budget reallocation rather than new program growth, and the negative outlayed amount suggests potential scope reduction or administrative adjustments.

2 total filings
· daily

General Federal Contracts — September 27, 2026

This digest covers two large, competitively awarded civilian contracts totaling $1.03 billion, with zero defense exposure. The dominant theme is sustained federal investment in IT services and border security operations, with Parsons Corporation securing a $612M GSA FEDSIM task order for computer systems design and Loyal Source Government Services winning a $421M DHS/CBP medical screening contract. The highest-conviction signal is the neutral-to-positive competitive win for Loyal Source, but the contract's performance period ended in 2022, limiting forward revenue visibility. Key risks include the Parsons contract being a modification with a negative outlayed amount (-$64,804), suggesting budget reallocation rather than new growth, and both contracts having finite end dates with no guaranteed follow-on work.

2 total filings
· daily

New Federal Contractors — September 26, 2026

The single contract analyzed represents a $248.4M civilian award from NASA to Universities Space Research Association (USRA) for academic mission R&D services, with zero defense-related obligations. The cost-plus-fixed-fee structure provides low profit volatility but capped upside, typical of nonprofit research contracts. The highest-conviction signal is neutral, reflecting stable near-term revenue but significant renewal risk as the contract expires in November 2024. Key watch items include NASA's budget trajectory for Ames Research Center and USRA's ability to secure follow-on work, given $143.6M already outlayed.

1 total filings